X-Authentication-Warning: delorie.com: mail set sender to geda-user-bounces using -f
X-Recipient: geda-user AT delorie DOT com
X-CMAE-Analysis: v=2.4 cv=DquTREz+ c=1 sm=1 tr=0 ts=60e79be7
 a=+cj0cO56Fp8x7EdhTra87A==:117 a=WZ/UB7iCicEj8r3JkhCb+Q==:17
 a=9+rZDBEiDlHhcck0kWbJtElFXBc=:19 a=dLZJa+xiwSxG16/P+YVxDGlgEgI=:19
 a=IkcTkHD0fZMA:10 a=e_q4qTt1xDgA:10 a=x2NsucaP20wPU1U0zQMA:9 a=QEXdDO2ut3YA:10
X-SECURESERVER-ACCT: glimrick AT epilitimus DOT com
X-Original-DKIM-Signature: v=1; a=rsa-sha256; q=dns/txt; c=relaxed/relaxed;
	d=epilitimus.com; s=default; h=Content-Transfer-Encoding:Content-Type:
	In-Reply-To:MIME-Version:Date:Message-ID:From:References:To:Subject:Sender:
	Reply-To:Cc:Content-ID:Content-Description:Resent-Date:Resent-From:
	Resent-Sender:Resent-To:Resent-Cc:Resent-Message-ID:List-Id:List-Help:
	List-Unsubscribe:List-Subscribe:List-Post:List-Owner:List-Archive;
	bh=1Jqgq2Ci5CKx54d5dzknv06oT9dOU7sTlyomgZuKg2g=; b=M9qZxpW6x6ZZLfbjDuSMgbe3Np
	VoYC4u/9KTr2GK1ibUdRcZ7OAOMOCLN+bOYFyXxXYNEr/pP4fvtqmxrClk4may1AAucRSMrflB7Wj
	vtF5AVSBiBs+9nuHpuSXuQ2wHhKm2jxQG3jNnUIZ6yTj0z6NXjl7WgzlTK4WUE+kHn65Idvx1k6Pv
	3uVePmaW5KUL0KU47IPVTOQWSC+IF7VQZU3urubg3kpl3mpv4MkdQngF+31Kw2fmYVuq6aaEh22oD
	mdD+BBZkKCcg6M3ccDly/PngN6liEW9CdL3RcQxwuEnbbsg8NEq9EjKWN3JcH/4poectkVCb5xBxl
	tWJ7a/7w==;
Subject: Re: [geda-user] Thank you - some requests and an offer
To: geda-user AT delorie DOT com
References: <20210707101437 DOT 2c7c63a6 AT queeg> <YOayUYFK9b1GiBoB AT lepton>
 <alpine DOT DEB DOT 2 DOT 21 DOT 2107081429220 DOT 1847 AT nimbus>
 <516720E8-7097-4943-89FB-EB0F53B38AD1 AT noqsi DOT com>
 <alpine DOT DEB DOT 2 DOT 21 DOT 2107082014520 DOT 1873 AT nimbus>
 <420493B5-5B8C-447C-9D66-5D46AFD963E1 AT noqsi DOT com>
 <20210708202955 DOT 21956 DOT qmail AT stuge DOT se>
 <A054EE4E-3819-42C7-9B56-B3644AD8AC39 AT noqsi DOT com>
From: "Glenn (glimrick AT epilitimus DOT com) [via geda-user AT delorie DOT com]" <geda-user AT delorie DOT com>
Message-ID: <ec1e6be0-4733-b54c-a119-c8d2297df611@epilitimus.com>
Date: Thu, 8 Jul 2021 16:44:20 -0800
User-Agent: Mozilla/5.0 (X11; Linux x86_64; rv:60.0) Gecko/20100101
 Firefox/60.0 SeaMonkey/2.53.3
MIME-Version: 1.0
In-Reply-To: <A054EE4E-3819-42C7-9B56-B3644AD8AC39@noqsi.com>
Content-Type: text/plain; charset=UTF-8
Content-Transfer-Encoding: 8bit
X-AntiAbuse: This header was added to track abuse, please include it with any abuse report
X-AntiAbuse: Primary Hostname - a2plcpnl0121.prod.iad2.secureserver.net
X-AntiAbuse: Original Domain - delorie.com
X-AntiAbuse: Originator/Caller UID/GID - [47 12] / [47 12]
X-AntiAbuse: Sender Address Domain - epilitimus.com
X-Get-Message-Sender-Via: a2plcpnl0121.prod.iad2.secureserver.net: authenticated_id: glimrick AT epilitimus DOT com
X-Authenticated-Sender: a2plcpnl0121.prod.iad2.secureserver.net: glimrick AT epilitimus DOT com
X-Source: 
X-Source-Args: 
X-Source-Dir: 
X-CMAE-Envelope: MS4xfNJ/HqHmr+GGhrmdQvmokef0XiWcoDGQmrZLQHE5CMSPvZv6n42CumyfxoOtveKeIRXW6Ythoz4ks0oArGoOsTLvnJu83suy+D0kKzmNZGQwWYGJYh2P
 Tv41VA3/WwnG9WhO8+Bbk4LcFXqy5K3TWY9G8tyuTZMgRA/x6bsnGNoVmVBfqCmwmqGUkygGFsD2nfdQDUcCrOA+4OFwpLzHMLqW2E58R3WmXWc9ZgQ15vUn
Reply-To: geda-user AT delorie DOT com
Errors-To: nobody AT delorie DOT com
X-Mailing-List: geda-user AT delorie DOT com
X-Unsubscribes-To: listserv AT delorie DOT com
Precedence: bulk

John Doty wrote:
> Have *you* mastered Xorn?
>
>
> Personally, I’m reasonably familiar with Python, but I found Xorn
> impenetrable. That’s why I now use Lepton. Roland is impressively
> productive with Xorn, but I can’t figure out how to do my custom stuff
> with it.
>
As someone that started from zero with no preexisting experience in
scheme, python, or xorn,  while I do not claim to have mastered xorn by
any means I have been able to figure out how to do everything I wanted
to do, including a few things Roland would prefer I didn't do.

I have also found Roland to be quite easy to work with (even when we
don't see eye to eye), while I have found some individuals from the
lepton side to be less than interested in any ideas which did not fit
into their preexisting paradigm.